4//SEC Filing
Boston Megan 4
Accession 0001062993-20-006255
CIK 0001808898other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:53 PM ET
Size
5.1 KB
Accession
0001062993-20-006255
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2020-12-09+142,172→ 142,172 totalExercise: $2.98Exp: 2030-12-09→ Common Stock (142,172 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808923
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 4:53 PM ET
- Size
- 5.1 KB